Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Barchart
Barchart
Rashmi Kumari

Is Xylem Stock Underperforming the Nasdaq?

Xylem Inc. (XYL), headquartered in Washington, D.C., is a global leader in water technology dedicated to addressing the world's most critical water challenges. With a market cap of $29.3 billion, the company provides advanced technologies and services for water management, treatment, and transportation, empowering communities and industries worldwide while fostering environmental stewardship and sustainable growth.

Companies with a market cap of $10 billion or more are classified as “large-cap stocks,” Xylem fits this category. Xylem delivers reliable and forward-thinking water technology solutions by combining advanced engineering, cutting-edge innovation, and a steadfast commitment to sustainability. 

Shares of the water technology company have fallen 17.4% from their 52-week high of $146.08, hit on May 21. The stock is down 7.8% over the past three months, significantly underperforming the broader Nasdaq Composite’s ($NASX12.7% gain during the same time frame.

www.barchart.com

Over the long term, XYL has achieved a YTD gain of 5.5% and returned 10.5% over the past 52 weeks. In comparison, the NASX has risen 32.7% in 2024 and 35.2% over the past year.

Since late October, XYL has been trading below its 200-day and 50-day moving averages, signaling a bearish trend.

www.barchart.com

On Oct. 31, Xylem's shares fell 6.5% after the company reported mixed Q3 results. Revenue of $2.1 billion rose 1.3% year over year but missed Wall Street estimates by 3.2%, while adjusted EPS of $1.11 met expectations. EBITDA came in slightly below forecasts at $447 million. 

Despite a consistent gross margin of 37.3%, the operating margin improved significantly to 13.3% from 9.2% in the prior year, reflecting better operational efficiency.

The company lowered its full-year revenue guidance to $8.5 billion at the midpoint, a modest 0.6% reduction, but maintained its adjusted EPS guidance at $4.23. 

Xylem's competitor, Parker Hannifin Corporation (PH), has outperformed XYL over the past year. Shares of Parker Hannifin gained 45.8% in 2024 and returned 10.6% over the past 52 weeks.

Wall Street analysts hold a cautiously optimistic view of XYL's prospects. Of the 18 analysts covering the stock, the consensus rating is “Moderate Buy.” Its mean price target of $152.07 indicates a potential upside of 26.1% from its current level.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.